investorscraft@gmail.com

Intrinsic Value of Premier, Inc. (PINC)

Previous Close$21.08
Intrinsic Value
Upside potential
Previous Close
$21.08

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Premier, Inc. operates as a healthcare improvement company, leveraging data-driven insights and collaborative networks to enhance clinical and financial outcomes for providers, suppliers, and patients. The company generates revenue primarily through group purchasing organization (GPO) services, supply chain solutions, and performance improvement technologies. Its GPO model aggregates purchasing power for healthcare providers, securing cost efficiencies, while its SaaS-based analytics platforms support operational and clinical decision-making. Premier holds a strong position in the U.S. healthcare services sector, serving over 4,400 hospitals and health systems. Its diversified offerings, including consulting and enterprise analytics, differentiate it from pure-play GPOs, reinforcing its role as an integrated healthcare solutions provider. The company benefits from long-term contracts and recurring revenue streams, underpinning stable cash flows. However, it faces competition from larger healthcare services firms and evolving regulatory pressures in the cost-conscious healthcare landscape.

Revenue Profitability And Efficiency

Premier reported revenue of $1.35 billion for FY 2024, with net income of $119.5 million, reflecting an 8.9% net margin. Diluted EPS stood at $1.04, while operating cash flow reached $296.6 million, demonstrating solid cash conversion. Capital expenditures of $81.2 million suggest moderate reinvestment needs, with free cash flow supporting shareholder returns and debt management. The company’s asset-light model contributes to steady profitability despite sector-wide margin pressures.

Earnings Power And Capital Efficiency

The company’s earnings power is anchored in its high-margin GPO and SaaS segments, which benefit from scalable operations. Return on invested capital (ROIC) remains healthy, supported by low capital intensity and recurring revenue streams. Premier’s ability to monetize data and analytics further enhances capital efficiency, though growth in these areas requires ongoing R&D and sales investments to maintain competitive differentiation.

Balance Sheet And Financial Health

Premier maintains a conservative balance sheet, with $125.1 million in cash and equivalents against $113.7 million in total debt, indicating a net cash position. The low leverage ratio provides flexibility for strategic investments or M&A. Working capital management appears efficient, with operating cash flow comfortably covering dividend obligations and modest capex requirements.

Growth Trends And Dividend Policy

Revenue growth has been steady, driven by expansion in high-margin performance services and GPO retention. The company pays a $0.84 annual dividend per share, yielding approximately 3.4%, reflecting a commitment to returning capital. Dividend coverage is robust, with a payout ratio near 80% of net income, though reinvestment in growth initiatives may temper future increases.

Valuation And Market Expectations

Trading at a forward P/E of ~15x, Premier is valued in line with healthcare services peers, reflecting its stable cash flows and moderate growth profile. Market expectations appear balanced, pricing in incremental gains from analytics adoption but limited upside from core GPO maturation. The stock’s yield may appeal to income-oriented investors amid sector volatility.

Strategic Advantages And Outlook

Premier’s integrated model and data capabilities position it to capitalize on healthcare’s shift toward value-based care. Near-term headwinds include GPO contract renewals and supplier pricing pressures, but long-term opportunities lie in analytics adoption and cross-selling. Management’s focus on margin expansion and tuck-in acquisitions could drive outperformance if execution risks are mitigated.

Sources

10-K filing, company investor relations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount